| 2021-11-12 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | Chief Executive Officer | 33,978 0.0288% | $171.52 | $5.83M | -4.89% | |
| 2021-08-13 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | Chief Executive Officer | 33,979 0.029% | $199.78 | $6.79M | -17.4% | |
| 2021-05-13 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | Chief Executive Officer | 33,979 0.0284% | $130.78 | $4.44M | +28.15% | |
| 2021-02-25 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | Chief Executive Officer | 33,979 0.0292% | $147.31 | $5.01M | +16.2% | |
| 2020-11-19 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | Chief Executive Officer | 34,765 0.0303% | $124.23 | $4.32M | +32.94% | |
| 2020-08-20 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | Chief Executive Officer | 34,765 0.0299% | $136.13 | $4.73M | +3.58% | |
| 2020-05-20 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | Chief Executive Officer | 34,765 0.0302% | $143.22 | $4.98M | -3.49% | |
| 2020-02-20 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | Chief Executive Officer | 34,765 0.0305% | $131.85 | $4.58M | +2.46% | |
| 2019-10-14 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | Chief Executive Officer | 49,456 0.0444% | $79.45 | $3.93M | +61.38% | |
| 2019-05-15 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | Chief Executive Officer | 98,914 0.0578% | $43.22 | $4.27M | +35.23% | |
| 2018-07-25 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | Chief Executive Officer | 100,000 0.0989% | $105.39 | $10.54M | -22.81% | |
| 2017-11-22 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | Chief Executive Officer | 146,830 0.1511% | $130.90 | $19.22M | -23.19% | |
| 2017-11-15 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | Chief Executive Officer | 148,000 0.1551% | $126.86 | $18.78M | -18.64% | |
| 2017-09-14 | Sale | bluebird bio, Inc. BLUE | director | 37,736 0.0823% | $131.21 | $4.95M | +30.49% | |
| 2017-08-24 | Sale | bluebird bio, Inc. BLUE | director | 22,170 0.0472% | $95.81 | $2.12M | +74.24% | |
| 2017-08-02 | Sale | bluebird bio, Inc. BLUE | director | 5,508 0.0128% | $96.74 | $532,850 | +89.1% | |
| 2017-03-03 | Sale | bluebird bio, Inc. BLUE | director | 27,678 0.0678% | $85.02 | $2.35M | +46.91% | |
| 2016-07-20 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | CEO | 30,150 0.0351% | $65.58 | $1.98M | -21.11% | |
| 2016-07-19 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | CEO | 30,152 0.0351% | $63.81 | $1.92M | -19.01% | |
| 2016-04-20 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | Chief Executive Officer | 30,150 0.0354% | $67.51 | $2.04M | -22.16% |